scholarly journals The American Society for Stereotactic and Functional Neurosurgery Position Statement on Laser Interstitial Thermal Therapy for the Treatment of Drug-Resistant Epilepsy

Neurosurgery ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Chengyuan Wu ◽  
Jason M. Schwalb ◽  
Joshua M. Rosenow ◽  
Guy M. McKhann ◽  
Joseph S. Neimat
2019 ◽  
Vol 32 (2) ◽  
pp. 237-245 ◽  
Author(s):  
Shoichi Shimamoto ◽  
Chengyuan Wu ◽  
Michael R. Sperling

2017 ◽  
Vol 208 (1) ◽  
pp. 48-56 ◽  
Author(s):  
Kofi-Buaku Atsina ◽  
Ashwini D. Sharan ◽  
Chengyuan Wu ◽  
James J. Evans ◽  
Michael R. Sperling ◽  
...  

2021 ◽  
pp. jnnp-2021-326185
Author(s):  
Niravkumar Barot ◽  
Kavita Batra ◽  
Jerry Zhang ◽  
Mary Lou Klem ◽  
James Castellano ◽  
...  

BackgroundApproximately 1/3 of patients with epilepsy have drug-resistant epilepsy (DRE) and require surgical interventions. This meta-analysis aimed to review the effectiveness of MRI-guided laser interstitial thermal therapy (MRgLITT) in DRE.MethodsThe Population, Intervention, Comparator and Outcome approach and Preferred Reporting Items for Systematic Reviews and Meta-Analyses were followed. PubMed, MEDLINE and EMBASE databases were systematically searched for English language publications from 2012 to Nov 2020. Data on the prevalence outcome using the Engel Epilepsy Surgery Outcome Scale (Class I–IV), and postoperative complications were analysed with 95% CIs.ResultsTwenty-eight studies that included a total of 559 patients with DRE were identified. The overall prevalence of Engel class I outcome was 56% (95% CI 0.52% to 0.60%). Hypothalamic hamartomas (HH) patients had the highest seizure freedom rate of 67% (95% CI 0.57% to 0.76%) and outcome was overall comparable between mesial temporal lobe epilepsy (mTLE) (56%, 95% CI 0.50% to 0.61%) and extratemporal epilepsy (50% 95% CI 0.40% to 0.59%). The mTLE cases with mesial temporal sclerosis had better outcome vs non-lesional cases of mTLE. The prevalence of postoperative adverse events was 19% (95% CI 0.14% to 0.25%) and the most common adverse event was visual field deficits. The reoperation rate was 9% (95% CI 0.05% to 0.14%), which included repeat ablation and open resection.ConclusionMRgLITT is an effective and safe intervention for DRE with different disease aetiologies. The seizure freedom outcome is overall comparable in between extratemporal and temporal lobe epilepsy; and highest with HH.Trail registration numberThe study protocol was registered with the National Institute for Health Research (CRD42019126365), which serves as a prospective register of systematic reviews. It is an international database of prospectively registered systematic reviews with a focus on health-related outcomes. Details about the protocol can be found at https://wwwcrdyorkacuk/PROSPERO/.


Neurosurgery ◽  
2019 ◽  
Vol 87 (2) ◽  
pp. E126-E129 ◽  
Author(s):  
Nader Pouratian ◽  
Gordon Baltuch ◽  
W Jeff Elias ◽  
Robert Gross

Abstract Magnetic resonance-guided focused ultrasound thalamotomy is a novel tool in the neurosurgical armamentarium for management of essential tremor (ET). Given the recent introduction of this technology, the American Society of Stereotactic and Functional Neurosurgery (ASSFN), which acts as the joint section representing the field of stereotactic and functional neurosurgery on behalf of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons, provides here the expert consensus opinion on evidence-based best practices for the use and implementation of this treatment modality. Indications for treatment are outlined, including confirmed diagnosis of ET, failure to respond to first-line therapies, disabling appendicular tremor, and unilateral treatment are detailed, based on current evidence. Contraindications to therapy are also detailed. Finally, the evidence and authority on which the ASSFN bases this consensus position statement is detailed.


2021 ◽  
Vol 12 ◽  
Author(s):  
Alessandro Consales ◽  
Erica Cognolato ◽  
Mattia Pacetti ◽  
Maria Margherita Mancardi ◽  
Domenico Tortora ◽  
...  

Magnetic resonance-guided laser interstitial thermal therapy (MR-gLiTT) is a novel minimally invasive treatment approach for drug-resistant focal epilepsy and brain tumors. Using thermal ablation induced by a laser diode implanted intracranially in a stereotactic manner, the technique is highly effective and safe, reducing the risk associated with more traditional open surgical approaches that could lead to increased neurological morbidity. Indications for MR-gLiTT in pediatric epilepsy surgery include hypothalamic hamartoma, tuberous sclerosis complex, cavernoma-related epilepsy, SEEG-guided seizure onset zone ablation, corpus callosotomy, periventricular nodular heterotopia, mesial temporal lobe epilepsy, and insular epilepsy. We review the available literature on the topic and present our series of patients with drug-resistant epilepsy treated by MR-gLiTT. Our experience, represented by six cases of hypothalamic hamartomas, one case of tuberous sclerosis, and one case of dysembryoplastic neuroepithelial tumor, helps to confirm that MR-gLiTT is a highly safe and effective procedure for several epilepsy conditions in children.


Epilepsia ◽  
2015 ◽  
Vol 56 (10) ◽  
pp. 1590-1598 ◽  
Author(s):  
Evan Cole Lewis ◽  
Alexander G. Weil ◽  
Michael Duchowny ◽  
Sanjiv Bhatia ◽  
John Ragheb ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document